U.S. market Closed. Opens in 43 minutes

TELA | TELA Bio, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
Revenue58.45M41.42M29.46M18.21M15.45M8.27M4.25M
Cost of Revenue18.34M14.37M10.65M6.98M6.17M5.33M1.71M
Gross Profit40.11M27.04M18.81M11.23M9.27M2.94M2.53M
Operating Expenses84.19M66.05M48.26M36.51M28.43M22.88M19.46M
Selling, General & Admin74.57M57.11M41.52M32.25M24.28M18.55M13.67M
Research & Development9.62M8.94M6.74M4.25M4.15M4.34M5.79M
Other Operating Expenses2.63M-10.00K-228.00K45.00K351.00K70.00KN/A
Operating Income-44.08M-39.01M-29.45M-25.27M-19.16M-17.78M-16.92M
Other Expenses / Income-2.59M-5.29M-3.83M-3.52M-3.26M652.00K-4.41M
Before Tax Income-46.66M-44.30M-33.28M-28.79M-22.43M-21.09M-21.33M
Income Tax Expenses640.11K41.00K2.83M3.08M3.38M-1.51MN/A
Net Income-46.66M-44.34M-36.11M-31.88M-25.80M-21.09M-21.33M
Interest Expenses5.22M4.05M3.60M3.56M3.61M1.80M4.56M
Basic Shares Outstanding22.87M16.27M14.47M12.93M11.41M6.49M6.49M
Diluted Shares Outstanding22.87M16.27M14.47M12.93M11.41M6.49M6.49M
EBITDA-43.27M-39.02M-29.68M-25.23M-18.81M-18.62M-16.02M
EBITDA Margin-74.02%-94.20%-100.73%-138.53%-121.79%-225.09%-377.27%
EBIT-40.80M-40.24M-29.68M-25.23M-18.82M-20.80M-16.78M
EBIT Margin-69.80%-97.17%-100.73%-138.53%-121.82%-251.37%-395.19%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙